Here's the live share price of Global Longlife Hospital and Research along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Global Longlife Hospital and Research has declined 37.23% CAGR. Over the past year, the corresponding return has been -57.44%.
Global Longlife Hospital and Research’s current P/E of -5.86x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Global Longlife Hospital and Research | -18.53 | -40.67 | -48.23 | -42.65 | -57.44 | -33.57 | -37.23 |
| Apollo Hospitals Enterprise | 2.88 | -2.55 | -8.01 | -0.37 | 4.21 | 18.37 | 21.27 |
| Max Healthcare Institute | 8.71 | -1.07 | -7.65 | -18.21 | -7.54 | 33.18 | 41.79 |
| Fortis Healthcare | 0.39 | -9.57 | -15.38 | -0.31 | 31.33 | 45.64 | 38.31 |
| Narayana Hrudayalaya | -2.70 | -11.18 | -5.50 | -2.68 | 25.31 | 33.39 | 28.58 |
| Global Health | 7.86 | -5.99 | -11.11 | -15.02 | -2.62 | 36.99 | 22.32 |
| Aster DM Healthcare | 1.76 | -10.07 | -18.07 | -5.81 | 17.28 | 38.38 | 28.98 |
| Dr. Lal Pathlabs | 2.50 | -2.40 | -7.32 | -10.13 | 3.05 | 13.63 | 3.69 |
| Krishna Institute of Medical Sciences | -1.63 | -5.65 | -17.54 | -20.93 | -9.21 | 26.49 | 24.42 |
| Dr. Agarwals Health Care | 3.56 | -12.17 | -10.62 | 0.73 | 11.53 | 3.94 | 2.35 |
| Rainbow Childrens Medicare | -1.96 | -14.06 | -18.22 | -24.85 | -19.08 | 15.18 | 19.89 |
| Metropolis Healthcare | 5.80 | -2.01 | -1.23 | -3.45 | 7.22 | 15.26 | -1.84 |
| Vijaya Diagnostic Centre | 0.77 | -8.04 | -5.36 | -8.42 | -14.19 | 30.91 | 9.26 |
| Jupiter Life Line Hospitals | -7.24 | -10.17 | -19.61 | -9.96 | -24.94 | 5.10 | 3.03 |
| Healthcare Global Enterprises | -3.54 | -13.40 | -24.36 | -6.50 | 6.18 | 26.45 | 29.64 |
| Park Medi World | 0.23 | 3.85 | 3.85 | 3.85 | 3.85 | 1.27 | 0.76 |
| Thyrocare Technologies | -3.84 | -13.90 | -8.57 | -10.10 | 48.29 | 34.92 | 5.19 |
| Yatharth Hospital & Trauma Care Services | 8.88 | -8.21 | -19.42 | -8.75 | 44.04 | 24.27 | 13.93 |
| Kovai Medical Center and Hospital | -0.62 | -4.47 | -13.11 | -11.71 | -9.87 | 44.97 | 35.89 |
| Nephrocare Health Services | 0.60 | 7.78 | 12.47 | 12.47 | 12.47 | 3.99 | 2.38 |
Over the last one year, Global Longlife Hospital and Research has declined 57.44% compared to peers like Apollo Hospitals Enterprise (4.21%), Max Healthcare Institute (-7.54%), Fortis Healthcare (31.33%). From a 5 year perspective, Global Longlife Hospital and Research has underperformed peers relative to Apollo Hospitals Enterprise (21.27%) and Max Healthcare Institute (41.79%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 14.78 | 14.91 |
| 10 | 16.85 | 16.51 |
| 20 | 19.44 | 18.4 |
| 50 | 20.51 | 20.48 |
| 100 | 22.44 | 22.21 |
| 200 | 24.93 | 25.31 |
In the latest quarter, Global Longlife Hospital and Research saw a drop in promoter holding to 35.44%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 64.56% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Jan 07, 2026, 9:31 PM IST | Global Longlife Hosp - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Dec 09, 2025, 12:49 AM IST | Global Longlife Hosp - Announcement under Regulation 30 (LODR)-Resignation of Director |
| Nov 12, 2025, 8:50 PM IST | Global Longlife Hosp - Unaudited Financial Results For The Half Year Ended September 30, 2025 Along With Limited Review Repor |
| Nov 12, 2025, 8:42 PM IST | Global Longlife Hosp - Board Meeting Outcome for Consideration And Approval Of Unaudited Financial Results For The Half Year |
| Nov 04, 2025, 10:10 PM IST | Global Longlife Hosp - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Half Year Ended On S |
Global Longlife Hospital and Research Ltd. is a Public Limited Listed company incorporated on 20/01/2012 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L85110GJ2012PLC068700 and registration number is 068700. Currently company belongs to the Industry of Hospitals & Medical Services. Company's Total Operating Revenue is Rs. 0.58 Cr. and Equity Capital is Rs. 10.50 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Global Longlife Hospital and Research is ₹13.19 as on Feb 06, 2026.
The Global Longlife Hospital and Research is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Global Longlife Hospital and Research is ₹13.85 Cr as on Feb 06, 2026.
Today’s highest and lowest price of Global Longlife Hospital and Research are ₹14.56 and ₹13.19.
The 52-week high/low is the highest and lowest price at which Global Longlife Hospital and Research stock has traded in the past 52-week or nearly a year. The 52-week high of Global Longlife Hospital and Research is ₹33.02 and 52-week low of Global Longlife Hospital and Research is ₹13.12 as on Feb 06, 2026.
The Global Longlife Hospital and Research has shown returns of -4.97% over the past day, -40.67% for the past month, -48.23% over 3 months, -57.44% over 1 year, -33.57% across 3 years, and -37.23% over 5 years.
P/E ratio of and PB ratio of Global Longlife Hospital and Research are -5.86 and 0.54 on Feb 06, 2026. While the company gives a dividend yield of 0.00 per annum.